Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1424621-40-8

Post Buying Request

1424621-40-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1424621-40-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1424621-40-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,4,6,2 and 1 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1424621-40:
(9*1)+(8*4)+(7*2)+(6*4)+(5*6)+(4*2)+(3*1)+(2*4)+(1*0)=128
128 % 10 = 8
So 1424621-40-8 is a valid CAS Registry Number.

1424621-40-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(4-bromo-2,6-dimethylphenyl)-2-(tert-butyl)diazene

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1424621-40-8 SDS

1424621-40-8Relevant articles and documents

The synthesis and SAR of calcitonin gene-related peptide (CGRP) receptor antagonists derived from tyrosine surrogates. Part 2

Han, Xiaojun,Civiello, Rita L.,Conway, Charles M.,Cook, Deborah A.,Davis, Carl D.,Degnan, Andrew P.,Jiang, Xiang-Jun,MacCi, Robert,Mathias, Neil R.,Moench, Paul,Pin, Sokhom S.,Schartman, Richard,Signor, Laura J.,Thalody, George,Tora, George,Whiterock, Valerie,Xu, Cen,MacOr, John E.,Dubowchik, Gene M.

, p. 1870 - 1873 (2013)

Various substituted indazole and benzoxazolone amino acids were investigated as d-tyrosine surrogates in highly potent CGRP receptor antagonists. Compound 3, derived from the 7-methylindazole core, afforded a 30-fold increase in CGRP binding potency compared with its unsubstituted indazole analog 1. When dosed at 0.03 mg/kg SC, compound 2 (a racemic mixture of 3 and its (S)-enantiomer) demonstrated robust inhibition of CGRP-induced increases in mamoset facial blood flow up to 105 min. The compound possesses a favorable predictive in vitro toxicology profile, and good aqueous solubility. When dosed as a nasal spray in rabbits, 3 was rapidly absorbed and showed good intranasal bioavailability (42%).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1424621-40-8